WASHINGTON, D.C. 20549 [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED NOVEMBER 30, 2022 or [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 001-37863 | --- | --- | |------------------------------------------------------------------------------------------------|-------------------------------------------------------| | Delaware (State or other jurisdiction of | 95-2 ...

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED AUGUST 31, 2022 or [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 001-37863 | --- | --- | |------------------------------------------------------------------------------------------------------------------------------|--------------------------------- ...

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K [X] Annual Report Under Section 13 or 15(d) of The Securities Exchange Act of 1934 For The Fiscal Year Ended May 31, 2022 or [ ] Transition Report Under Section 13 or 15(d) of The Securities Exchange Act Of 1934 | --- | --- | |----------------------------------------------------------------------------------------|-----------------------------------------------------| | | | | For The Transition Period From ______ | ______ | | Commission Fil ...

Copyright © 2022 Biomerica. All Rights Reserved BIOMERICA ) Investor Presentation A u g u s t 2022 Forward-Looking Statement The Private Securities Litigation Reform Act of 1995 provides a "safe harbor" for forward-looking statements. Certain information included in this presentation (as well as information included in oral statements or other written statements made or to be made by Biomerica) contains statements that are forward-looking, including statements other than statements of historical facts; such ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED FEBRUARY 28, 2022 OR [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 001-37863 BIOMERICA, INC. (Former name, former address and former fiscal year, if changed since last report.) Securities registered pursuant to Section 12(b) ...

| --- | --- | --- | |-----------------------------------------------------------|-----------------------------------------------------|-------| | | | | | (TITLE OF EACH CLASS) ----------------------------------- | (TICKER SYMBOL) ----------------------------------- | | | Common, par value $.08 | BMRA | | (NAME OF EACH EXCHANGE ON WHICH REGISTERED) ------------------------------------------------------------------------------- NASDAQ Capital Market Indicate by check whether the registrant (1) filed all repor ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED AUGUST 31, 2021 OR [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 001-37863 BIOMERICA, INC. (Former name, former address and former fiscal year, if changed since last report.) Securities registered pursuant to Section 12(b) of ...

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K [X] Annual Report Under Section 13 or 15(d) of The Securities Exchange Act of 1934 For The Fiscal Year Ended May 31, 2021 or [ ] Transition Report Under Section 13 or 15(d) of The Securities Exchange Act Of 1934 For The Transition Period From ______ To ______ | --- | --- | |----------------------------------------------------------------------------------------|------------------------------------------| | | | | Commission File Number: | 00 ...

Investor Presentation | --- | --- | --- | --- | --- | |-------|-------|-------|-------|---------------| | | | | | | | | | | | | | | | | | | | | | | | Investor | | | | | | | | | | | | Presentation | | | | | | June 2021 | | | | | | NASDAQ: BMRA | Forward-Looking Statement The Private Securities Litigation Reform Act of 1995 provides a "safe harbor" for forward-looking statements. Certain information included in this presentation (as well as information included in oral statements or other written statements m ...

Investor Presentation | --- | --- | --- | --- | --- | |-------|-------|-------|-------|---------------| | | | | | | | | | | | | | | | | | | | | | | | Investor | | | | | | | | | | | | Presentation | | | | | | June 2021 | | | | | | NASDAQ: BMRA | Forward-Looking Statement The Private Securities Litigation Reform Act of 1995 provides a "safe harbor" for forward-looking statements. Certain information included in this presentation (as well as information included in oral statements or other written statements m ...